Atypical hemolytic-uremic syndrome after COVID-19 vaccine: A case report.

Marcos Adriano Garcia CamposRômullo José Costa AtaídesMaxwell Cabral FerreiraAdriano Soares AlvesGyl Eanes Barros Silva

Published in: Immunity, inflammation and disease (2024)

This case illustrates the rare occurrence of aHUS following COVID-19 vaccination, with unique characteristics compared to previous reports. Despite the critical role of vaccination in pandemic control, emerging adverse events, such as vaccine-related TMA, must be recognized and investigated. Additional clinical trials are imperative to comprehend the clinical features and pathophysiological mechanisms underlying TMA associated with COVID-19 vaccination.

Keyphrases

coronavirus disease
sars cov
clinical trial
respiratory syndrome coronavirus
risk assessment
emergency department
randomized controlled trial
atomic force microscopy
phase ii
high resolution
single molecule
study protocol